Daojun Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Gut microbiota and health
Papers in
-
- Prostate Cancer Treatment and Research 14
- Prostate Cancer Diagnosis and Treatment 4
- Renal cell carcinoma treatment 4
-
- Sperm and Testicular Function 8
- Co-authors
- Fangpeng Shu (17 shared papers)Xumin Zhou (12 shared papers)Xian‐Lu Song (8 shared papers)Yu‐Zhong Yu (10 shared papers)Chong Wang (7 shared papers)Shan‐Chao Zhao (11 shared papers)Kaihui Wu (6 shared papers)Taowei Yang (8 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (4 papers)Cell Death Discovery (3 papers)Asian Journal of Andrology (2 papers)Cell Death and Disease (2 papers)Molecular Cancer (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Daojun Lv
47 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 220
- Molecular Biology 673
- Pulmonary and Respiratory Medicine 274
- Oncology 156
- Reproductive Medicine 57
Countries citing papers authored by Daojun Lv
This map shows the geographic impact of Daojun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daojun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daojun Lv more than expected).
Fields of papers citing papers by Daojun Lv
This network shows the impact of papers produced by Daojun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daojun Lv. The network helps show where Daojun Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Daojun Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 177 | |
| 2 | 2022 | 163 | |
| 3 | 2022 | 118 | |
| 4 | 2018 | 98 | |
| 5 | 2021 | 89 | |
| 6 | 2022 | 75 | |
| 7 | 2019 | 61 | |
| 8 | 2023 | 53 | |
| 9 | 2020 | 48 | |
| 10 | 2021 | 43 | |
| 11 | 2021 | 42 | |
| 12 | 2021 | 39 | |
| 13 | 2022 | 39 | |
| 14 | 2017 | 35 | |
| 15 | 2024 | 33 | |
| 16 | 2016 | 29 | |
| 17 | Expression of PGAM1 in renal clear cell carcinoma and its clinical significance. | 2015 | 27 |
| 18 | 2019 | 25 | |
| 19 | 2018 | 24 | |
| 20 | 2017 | 23 |
About Daojun Lv
Daojun Lv is a scholar working on Pulmonary and Respiratory Medicine, Reproductive Medicine, Molecular Biology, Cancer Research and Clinical Biochemistry, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Circular RNAs in diseases (9 papers), Sperm and Testicular Function (8 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (4 papers), RNA modifications and cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (220 citations), Molecular Biology (673 citations), Pulmonary and Respiratory Medicine (274 citations), Oncology (156 citations) and Reproductive Medicine (57 citations). Daojun Lv has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Fangpeng Shu, Xumin Zhou, Xian‐Lu Song, Yu‐Zhong Yu, Chong Wang, Shan‐Chao Zhao, Kaihui Wu, Taowei Yang, Junqi Luo and Xiangkun Wu. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Cell Death Discovery, Asian Journal of Andrology, Cell Death and Disease and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.